Ardent Health Partners, Inc.

NYSE•ARDT

CEO: Mr. Martin J. Bonick FACHE, M.H.A.

セクター: Healthcare

業種: Medical - Care Facilities

上場日:

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

連絡先情報

340 Seven Springs Way, Suite 100, Brentwood, TN, 37027, United States

615-296-3000

www.ardenthealth.com

時価総額

$1.34B

PER (TTM)

9.7

16.3

配当利回り

52週高値

$15.48

52週安値

$8.07

52週レンジ

18%

順位41Top 44.9%

4.0

F-Score

改良版 Piotroski 分析

8年ファンダメンタル

堅調 • 4 / 9 ポイント

スコアレンジ (0-9)

8-9: 価値が優れている

6-7: 基礎体質が強い

4-5: 全体的に堅調

0-3: パフォーマンスが弱い

データ期間: 2018-2025

財務ダッシュボード

Q4 2025 データ

売上高

$1.61B+0.00%

直近4四半期の推移

EPS

$0.32+0.00%

直近4四半期の推移

フリーCF

$137.83M+0.00%

直近4四半期の推移

2025 Q3 決算ハイライト

主なハイライト

Revenue Growth Strong Total revenue grew 8.8% to $1.58 B for the quarter; 9-month revenue increased 8.2% to $4.72 B.

Operating Cash Flow Improves Nine-month cash provided by operations reached $247.075 M, up $51.618 M from prior period, supporting liquidity.

Liquidity Position Solid Cash and equivalents totaled $609.441 M at period end; available liquidity stood at $903.8 M for needs.

Debt Refinancing Completed Term Loan B refinanced in September 2025, reducing applicable interest rate by 50 basis points immediately.

リスク要因

Quarterly Net Loss Reported Net loss attributable to Ardent Health, Inc. was $(23.478) M for the quarter, reversing prior period income.

Professional Liability Reserves Surge $47.2 M professional liability reserve increase, driven by New Mexico adverse claim developments, impacted Q3 results.

Regulatory Environment Uncertainty OBBBA legislation introduces uncertainty regarding Medicaid funding mechanisms and potential federal payment reductions.

Labor Costs Remain High Competition and minimum wage increases in some markets create ongoing pressure on salaries and benefits expenses.

見通し

Continue Acquisition Strategy Completed acquisition of 18 urgent care clinics in January 2025 for $27.5 M, planning further growth.

Manage Revenue Estimate Change Implemented new revenue accounting system, resulting in $42.6 M revenue decrease due to improved collectability estimates.

Capital Expenditures Planned Expect to finance future capital expenditures with internally generated funds and borrowed funds for modernization.

Debt Covenants Compliance Management believes compliance maintained with all financial covenants under the Ventas Master Lease as of September 30, 2025.

同業比較

売上高 (TTM)

ARDT

$6.32B

+6.0%

SEM

$5.45B

+15.8%

ACHC

$3.31B

+5.0%

粗利益率 (最新四半期)

ARDT

165.5%

-25.6pp

IBRX

88.9%

-12.9pp

NHC

67.7%

+1.8pp

主要指標

銘柄コード	時価総額	PER (TTM)	ROE (TTM)	負債比率
IBRX	$8.63B	-23.6	64.3%	175.0%
BKD	$3.31B	-12.4	-523.8%	112.0%
NHC	$2.51B	20.8	11.6%	5.7%

長期トレンド

直近4四半期

売上高

純利益

営業キャッシュフロー

4四半期売上高CAGR

2.3%

緩やかな成長

4四半期純利益CAGR

2.8%

収益性の緩やかな改善

キャッシュフロー安定性

75%

キャッシュフローの変動が大きい

深度リサーチ

次回決算:2026年5月12日

EPS:$0.18

売上高:$1.57B

財務データ

決算説明会

財務レポート

ニュース

損益計算書

バランスシート

キャッシュフロー計算書

財務比率

変化率

損益計算書	直近12ヶ月

データなし